Indegene IPO subscription ke liye ₹1,841.76 crore tak khula tha. Listing gain ke baad share price mein giravat. Jaaniye Indegene ki karobari sehat aur IPO ke paise ka istemaal kaise hoga.
- Indegene IPO Listing aur Share Price ka Safar
- Indegene: Digital Services aur Business Model
- Financial Health aur Growth Rate
- Conclusion: Indegene ki Aage Ki Yojana
1. Indegene IPO Listing aur Share Price ka Safar: Indegene ka ₹1,841.76 crore ka IPO subscription ke liye 6-8 May tak khula tha.
Is IPO ko niveshakon ka shandaar response mila tha aur overall 70.30 guna subscription hua tha.
Qualified Institutional Buyers (QIBs) ke liye reserved portion mein 192.72 guna subscription hua, Non-Institutional Investors (NIIs) ka portion 55.91 guna aur Retail Investors ka portion 7.86 guna bhara gaya tha. Is IPO ke tehat 760 crore rupees ke naye share jaari hue the.
Iske alawa 2 rupees ki face value waale 2,39,32,732 share offer for sale window ke tehat bik gaye hain.
Offer for sale ke paisa to share bechne wale shareholders ko milega. Vahi naye shareon ke zariye jute gaye paise ka istemal company subsidiary ka karz chukane, apna aur subsidiary ki working capital ki zaruraton ko poora karne aur aam corporate udeshyon mein hoga.
2. Indegene: Digital Services aur Business Model: Indegene, jo 1998 mein bani thi, digital services pradan karti hai aur drug development, clinical trials, regulatory submission, pharmacovigilance, complaints management, aur sales/marketing support mein sahayog karti hai.
December 2024 tak ke ankon ke mutabiq iske 65 clients hain. Iska karobar Bharat ke alawa uttari America, Europe, China ke sath-sath aur kai deshon mein phaila hua hai.
Company ke financial health ki baat karein toh yeh lagatar majboot hui hai. Vyaparik varsh 2021 mein isne 149.41 crore rupees ka shudh munafa hasil kiya tha jo agle varsh 2022 mein uchhal kar 162.82 crore rupees aur vyaparik varsh 2023 mein 266.10 crore rupees par pahunch gaya.
Is dauran company ka revenue salana lagbhag 54 pratishat ki chakravritti dar (CAGR) se badhkar 2,364.10 crore rupees par pahunch gaya.
Pichle vyaparik varsh 2023-24 ki baat karein toh April-December 2023 mein, isne 241.90 crore rupees ka shudh munafa aur 1,969.75 crore rupees ka revenue hasil kiya tha.
3. Financial Health aur Growth Rate: Indegene ka IPO listing gain ke baad share price mein thodi giravat aayi hai.
Lekin company ka business model aur financial health strong hai, aur iski aage ki yojanaon mein bhi vishwas hai.
Investors ko long-term mein bhi Indegene mein vishwas rakhte hue dekhte rehna chahiye.
Conclusion: Indegene ka IPO listing gain ke baad share price mein thodi giravat aayi hai.
Lekin company ka business model aur financial health strong hai, aur iski aage ki yojanaon mein bhi vishwas hai.
Investors ko long-term mein bhi Indegene mein vishwas rakhte hue dekhte rehna chahiye.